Betaferon Injection Management: Non-Interventional Study on Personal Digital Assistant (PDA)Supported Effects on Adherence to a Long-Term Injection Therapy (BETAPATH)
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2015
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms BETAPATH
- Sponsors Bayer
- 24 Sep 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Jul 2014.
- 18 Mar 2014 Planned end date changed from 1 Mar 2014 to 1 May 2014 as reported by ClinicalTrials.gov.